Acute kidney injury and adverse renal events in patients receiving SGLT2-inhibitors: A systematic review and meta-analysis
Author:
Publisher
Public Library of Science (PLoS)
Subject
General Medicine
Reference20 articles.
1. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials;TA Zelniker;Lancet,2019
2. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes;B Zinman;N Engl J Med,2015
3. Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes;C Wanner;N Engl J Med,2016
4. Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);MJ Davies;Diabetes Care,2018
5. Acute kidney injury from SGLT2 inhibitors: potential mechanisms;K Hahn;Nat Rev Nephrol,2016
Cited by 99 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cardiovascular benefits of SGLT2 inhibitors and GLP-1 receptor agonists through effects on mitochondrial function and oxidative stress;Free Radical Biology and Medicine;2024-03
2. SGLT2 inhibitor dapagliflozin protects the kidney in a murine model of Balkan nephropathy;American Journal of Physiology-Renal Physiology;2024-02-01
3. Effect of SGLT2 Inhibitor Dapagliflozin on Biomarkers of Acute Kidney Injury in Patients with Acute Heart Failure: A Randomized Controlled Trial;2024-02-01
4. Comparison of Effectiveness Among Different Sodium‐Glucose Cotransoporter‐2 Inhibitors According to Underlying Conditions: A Network Meta‐Analysis of Randomized Controlled Trials;Journal of the American Heart Association;2024-01-31
5. Safety of sodium‐glucose cotransporter 2 inhibitors drugs among heart failure patients: a systematic review and meta‐analysis;ESC Heart Failure;2023-12-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3